Launch of Next-Generation Non-Valved Glaucoma Drainage Device for Personalized Patient Care

Published: 04 Sep 2025

Author: Precedence Research

Share :

New World Medical has introduced the Ahmed ClearPath ST, a new non-valved glaucoma drainage device that offers glaucoma specialists worldwide a wider range of surgical options. The ClearPath ST builds upon the concepts of the original Ahmed ClearPath, incorporating several major design improvements aimed at enhancing safety and improving postoperative control. This provides surgeons with greater flexibility to tailor the treatment to the specific needs of each patient. Some of its new capabilities include a smaller tube lumen, a 6-0 Prolene ripcord suture with a pre-threaded 6-0 suture, and a 25-gauge needle to aid scleral tunneling.

The Ahmed ClearPath ST was introduced into the market when the interest in new methods of glaucoma treatment was growing at a blistering pace. Surgeons all over the world are busy trying to find superior technologies that offer efficacy and safety to patients with glaucoma. Over 76 million people in the world live with a condition that is a major cause of irreversible blindness. The smaller profile tube of the ClearPath ST, the globe-conforming flexible plate, and adjustable size exemplify New World Medical's commitment to addressing this pressing global health demand with innovations that are expected to enhance patient outcomes and surgeon confidence.

With glaucoma cases on the increase worldwide, the ClearPath ST has come at the right time. Its elegant design might be especially useful in areas where surgeons are juggling large patient throughputs with scarce resources, since its simplified functionality and adjustable size can make surgeries shorter and less complicated. Furthermore, the launch of smaller lumen tubes also coincides with the increased focus on the minimally invasive ophthalmic solutions currently introduced, with a high focus on patient comfort without compromising patient safety. This company is contributing to the creation of a future where glaucoma blindness is less common by investing in accuracy, flexibility, and assisting surgeons.

Executive’s Statement

Raymond Kong, Chief Commercial Officer, New World Medical

“The Ahmed ClearPath ST represents a significant step forward, allowing glaucoma specialists to overcome long-standing limitations associated with traditional tube shunts. The smaller diameter tube enables excellent pressure control, with the potential for enhanced safety and improved postoperative management, as well as personalization of treatment. New World Medical is committed to continuous innovation. The Ahmed ClearPath ST marks another milestone in our mission to deliver innovative solutions that empower surgeons and improve the lives of patients globally.”